| Net Cash Provided by (Used in) Operating Activities |
$32,291,217 |
USD |
-38% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$12,728,416 |
USD |
-2074% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Common Stock, Shares, Issued |
16,145,398 |
shares |
16% |
Q4 2025 |
Q3 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q3 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$169,558,210 |
USD |
-32% |
Q4 2025 |
Q3 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$10,508,514 |
USD |
1.3% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$2,217,080 |
USD |
44% |
Q4 2025 |
Q3 2026 |
| Deferred Tax Assets, Gross |
$2,456,671 |
USD |
53% |
Q4 2025 |
Q3 2026 |
| Deferred Income Tax Expense (Benefit) |
$81,121 |
USD |
-107% |
Q4 2025 |
Q3 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$6,200,000 |
USD |
|
Q1 2024 |
FY 2024 |
| Deferred Federal Income Tax Expense (Benefit) |
$232 |
USD |
-100% |
Q4 2025 |
Q3 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,908,125 |
USD |
|
Q2 2024 |
Q1 2024 |
| Deferred State and Local Income Tax Expense (Benefit) |
$16,343 |
USD |
-116% |
Q1 2024 |
FY 2024 |
| Interest Expense |
$900,000 |
USD |
80% |
Q3 2025 |
Q2 2026 |